GLP-1 Semaglutides: The Practitioner's Complete Guide

GLP-1 products are a major purchasing category for med spas. By the end of 2024, 60% of med spas offered GLP-1 programs . The same report recorded a 9% revenue change for those practices and a 2% decline for those that did not.

Patients ask about products such as Ozempic, Wegovy, and Rybelsus. Clinics need disciplined product-status, vendor, documentation, inventory, and regulatory checks before purchasing them.

Understanding GLP-1s and Semaglutides

GLP-1 means glucagon-like peptide-1. Semaglutide is the active ingredient in certain prescription products. The key procurement distinction is between an FDA-approved finished drug and a compounded preparation. Approval belongs to a specific product, manufacturer, labeling, and approved use. It does not extend to a compounded copy.

Semaglutide was first approved for type 2 diabetes in 2017. In 2021, the FDA approved a semaglutide product for chronic weight management. Confirm the exact product in the FDA database and review its current labeling. A published clinical overview provides background but does not replace product-level verification or authorize claims outside approved labeling.

Market research also reports that almost 40% of surveyed GLP-1 patients were new to the practice . Treat that figure as context, not a clinic forecast. Base purchasing on documented demand, cash flow, storage capacity, and lawful operations.

How Semaglutide Products Are Regulated and Sourced

Before ordering, verify the finished product, seller, and transaction path. Keep the manufacturer, National Drug Code when applicable, lot, expiration date, invoice, shipping record, and current labeling in the procurement file.

• Confirm whether the item is an FDA-approved finished drug or a compounded preparation.
• Verify the seller's active pharmacy, wholesaler, or distributor licenses.
• Match the product, strength, package, lot, and expiration date to the purchase record.
• Keep research links, including this published semaglutide paper , in an evidence file without turning findings into promotional claims.

Assign one owner to review licensing, FDA status, recalls, shortage updates, and supplier documents. Repeat the review when the vendor, product, manufacturer, fulfillment route, or state rule changes.

How to Integrate Semaglutide Procurement Into Aesthetic Medicine

Fit GLP-1 purchasing into existing medication controls. Define who can order and receive product, then reconcile each shipment against its purchase order before releasing inventory.

• Separate branded prescription products from aesthetic supplies in vendor and inventory records.
• Track supplies by item, supplier, lot when applicable, unit cost, reorder point, and expiration date.

Confirm packaging integrity, shipping time, required temperature evidence, and manufacturer excursion instructions. Record who accepted delivery and quarantine shipments with missing or inconsistent documents.

Budget for acquisition, freight, storage, staff time, waste, payment timing, and unused inventory. Keep purchasing separate from service forecasts so margins do not depend on treatment or patient-outcome assumptions.

Regulations Around Compounded Semaglutides

This area changes quickly. Clinics should review current federal guidance, state pharmacy rules, and the status of each supplying pharmacy before ordering or renewing a contract.

In early 2025, the FDA determined that the semaglutide injection shortage was resolved and announced enforcement-discretion wind-down periods. As a result, routine copies face substantial restrictions. The linked legal overview discusses why compounded semaglutide copies are now severely restricted.

Do not treat an old supplier relationship or shortage listing as current authority to purchase a compounded copy. Document the pharmacy's 503A or 503B status, licenses, the legal basis for the preparation, and the review date.

States can impose separate rules on GLP-1 prescribing, dispensing, and clinic operations. Verify the requirements in each clinic and patient jurisdiction before ordering, and repeat the check when rules change.

How to Structure Procurement Review and Follow-Up

A consistent supplier review protects the purchasing record. Before approving any source, the clinic should:

• Collect the supplier's legal name, physical address, ownership details, and order contacts
• Check current state and federal licenses against primary-source databases
• Review product listings, manufacturer details, labeling, and fulfillment terms
• Request invoices, shipping records, recall procedures, and chain-of-custody documentation

This catches mismatched names, expired licenses, unclear fulfillment routes, and products that differ from the approved description. Save dated evidence with the vendor file.

Watch for these procurement red flags:

• A routine compounded copy offered without a documented legal basis
• Missing or unverifiable 503A pharmacy or 503B outsourcing-facility information
• Labels, package details, or payment instructions that differ from the approved vendor record
• A seller that will not identify the manufacturer, dispensing pharmacy, or distribution path

Quarantine damaged packages, missing required temperature records, or lot and expiration mismatches. Escalate discrepancies before an item enters inventory.

Follow current manufacturer storage labeling. Use monitored equipment where required, log temperatures and excursions, rotate stock by expiration, and limit access. Instructions for one semaglutide product may not apply to another.

Review a new vendor at 1, 3, 6, and 12 months. Recheck licenses, FDA notices, recalls, deliveries, invoices, damage, expirations, and unresolved issues. Continue on a risk-based schedule.

How to Manage GLP-1 Program Costs and Procurement

GLP-1 purchasing conditions have changed. Do not build forecasts around continued access to inexpensive compounded copies or assume prior margins will continue.

Create separate budget lines for:

• Membership or program administration fees
• Optional aesthetic-service consultations and supplies
• Nutrition-coaching operations

A market whitepaper reported that GLP-1 patients spend 63% more with med spas and nearly four times more new clients. Use these as industry context. Model purchasing from clinic records, separating medication costs from membership, telehealth, and optional-service revenue.

Marketing materials should identify whether a reference is to an FDA-approved product or a compounded preparation. Review product names, approval statements, images, testimonials, and linked content before publication. Avoid before-and-after promotion, unapproved-use claims, and language that suggests a compounded product is equivalent to an FDA-approved drug.

How Portrait Supports GLP-1 Operations

A GLP-1 program adds scheduling, charting, payments, inventory, and compliance tasks. Portrait's operating technology brings these administrative functions into one workflow.

The workflow connects booking, good faith exam documentation, clinician oversight, visits, inventory, follow-up tasks, and rebooking. Clinics configure it for their services, staffing, and state requirements.

For clinical oversight, Portrait connects practices with a nationwide MD network . Resources support good faith exam steps and state-specific legal structures, including considerations in Texas and California. Clinics should confirm what applies to their location and model.

The Portrait Marketplace offers savings of up to 60% on select products. It is additive to existing representative relationships, letting clinics compare items, documentation, and pricing while keeping established supplier contacts.

The Future of GLP-1 Procurement

The linked industry forecast places the anti-obesity drug market at $95 billion by 2030. Because forecasts and availability change, use current FDA records, manufacturer information, and clinic demand when purchasing.

If you own a med spa, now is the time to formalize the purchasing controls behind any GLP-1 offering.

• Build physician-led governance for vendor approval and medication purchasing.
• Know your state's rules and document when they were last checked.
• Connect purchasing forecasts with storage capacity, inventory controls, and cash flow.

Most importantly, use clear systems to manage each operational step and retain the supporting records. Book an intro call with Portrait to see how its technology and Marketplace can support GLP-1 purchasing, inventory, and practice operations.

Related reading

• 503A vs 503B Pharmacy: What Your Practice Can Stock
• Who Can Buy Botox? Licensing Guide for Practices
• Compounded Tirzepatide 2026 - FDA Rule Change Guide
• Portrait vs Kyrios Systems: Which Software Is Better?
• Medical Spa Laws and Requirements in Arlington